Drawbacks of ovarian ablation with goserelin in women with breast cancer.

Authors

  • Sofia Franco Departamento de Medicina Materno-Fetal, Genética e Reprodução Humana, Hospitais da Universidade de Coimbra, Coimbra.
  • Paula Lupa
  • Carlos Guerra
  • Luís Pereira
  • Carlos F de Oliveira

DOI:

https://doi.org/10.20344/amp.1013

Abstract

In the last few years, ovarian ablation with GnRH agonists has been used as first-line adjuvant therapy in pre and perimenopausal breast cancer. These drugs suppress ovarian function in the hypothalamic-pituitary axis and they have adverse effects in other end-organs. A retrospective study was conducted on 35 premenopausal women, with breast cancer, and treated with goserelin, in order to investigate the effects of iatrogenic estrogen suppression. All women complaint of amenorrhea and only half of them referred hot-flashes, weight gain or arthralgias. Hot-flushes and arthralgias remit spontaneously in the end of the treatment. Osteodensitometry was used to access bone mass. There was a reduction in mineral bone mass and T-score at femoral neck and lumbar spine after the treatment with goserelin, but without statistical significance, except for the T-score in lumbar spine.

Downloads

Download data is not yet available.

Downloads

How to Cite

1.
Franco S, Lupa P, Guerra C, Pereira L, Oliveira CF de. Drawbacks of ovarian ablation with goserelin in women with breast cancer. Acta Med Port [Internet]. 2005 Apr. 30 [cited 2024 Nov. 23];18(2):123-7. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/1013

Issue

Vol. 18 No. 2 (2005): March-April

Section

Arquivo Histórico

License

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.

Crossref
Scopus
Google Scholar
Europe PMC